Position in TMO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$17,880,503
+$2,976,822 QoQ
Shares Held
35,664
+17.6% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
3.29%
of 13F equity value
Holder Rank
#507
of 2,606 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NUANCE INVESTMENTS, LLC holds $95,158,857 across 6 Diagnostics & Research names. TMO ranks #2 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
|
1,595,726 | $62,392,886 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
This page
|
35,664 | $17,880,503 | |
| 3 | DGX |
Quest Diagnostics Inc
|
27,470 | $5,822,266 | |
| 4 | WAT |
Waters Corp /De/
|
10,762 | $4,036,180 | |
| 5 | DHR |
Danaher Corp /De/
|
17,162 | $3,269,017 | |
| 6 | A |
Agilent Technologies, Inc.
|
13,235 | $1,758,005 |
All Filings in TMO
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,880,503 | 35,664 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $14,903,681 | 30,321 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $12,174,244 | 21,010 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $25,704,604 | 52,997 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $35,637,906 | 87,895 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $3,275,203 | 6,582 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $4,167,042 | 8,010 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $4,577,418 | 7,400 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $7,106,050 | 12,850 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $10,719,256 | 18,443 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $9,866,855 | 18,589 | Shares | Sole | 2024-02-07 | |
| No filing history on record for this holder in this stock. | ||||||